Jun 22, 2026 04:41PM
Jun 22, 2026 07:00AM
Jun 22, 2026 07:00AM
Jun 8, 2026 07:02AM
Jun 8, 2026 07:00AM
May 13, 2026 04:05PM
Apr 30, 2026 08:15AM NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026
Mar 19, 2026 05:10PM
Mar 16, 2026 07:02AM
Mar 16, 2026 07:00AM
Mar 10, 2026 07:02AM
Mar 10, 2026 07:00AM
Jan 8, 2026 04:07PM
Jan 8, 2026 04:05PM Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
Nov 18, 2025 06:31AM
Nov 14, 2025 05:00PM
Nov 6, 2025 06:30PM
Nov 6, 2025 06:30PM
Aug 6, 2025 04:01PM
Aug 6, 2025 04:01PM
Feb 7, 2025 10:00AM Eledon Pharmaceuticals (ELDN) Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
Feb 7, 2025 10:00AM
Oct 23, 2023 07:01AM
Oct 23, 2023 07:00AM
Sep 11, 2023 07:02AM
Sep 11, 2023 07:00AM
Jan 9, 2023 08:31AM
Jan 9, 2023 08:31AM Eledon Pharmaceuticals Provides Business and Pipeline Updates
Jan 9, 2023 08:30AM
Jan 9, 2023 08:30AM
Nov 14, 2022 04:01PM
Nov 14, 2022 04:01PM
Sep 7, 2022 09:19AM
Sep 6, 2022 05:34PM
Sep 6, 2022 04:03PM Eledon Pharmaceuticals (ELDN) Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy
Sep 6, 2022 04:01PM
Sep 6, 2022 04:01PM
Aug 11, 2022 04:01PM
Aug 11, 2022 04:01PM
Aug 1, 2022 05:49AM
Aug 1, 2022 05:00AM
Aug 1, 2022 05:00AM Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart for the Prevention of Rejection in Kidney Transplant Recipients
Jun 9, 2022 08:03AM
Jun 9, 2022 08:00AM
Jun 9, 2022 08:00AM
May 31, 2022 06:09AM
May 31, 2022 06:00AM
May 31, 2022 06:00AM
Mar 24, 2022 04:01PM Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Operating and Financial Results
Mar 24, 2022 04:01PM

324,317 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All